Condition
Chronic Graft-versus-host Disease (cGVHD) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Chronic Graft-versus-host Disease (cGVHD) clinical trials that are recruiting, in United States. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Comparing Ruxolitinib and Prednisone for treating chronic GVHD
This study is testing whether Ruxolitinib works better than Prednisone for adults with chronic graft-versus-host disease who need treatment.
-
Evaluating Vimseltinib for Chronic Graft-Versus-Host Disease in Adults
This study is testing if a new medication called vimseltinib can help adults with tough cases of chronic graft-versus-host disease feel better after other treatments haven't worked.
Related topics
Quick answers
How many Chronic Graft-versus-host Disease (cGVHD) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.